Codice QR

Real-world experience with TTFields in glioma patients with emphasis on therapy usage

Tumor Treating Fields (TTFields) has emerged as a significant adjunctive component in the treatment of high-grade gliomas following the EF-14 trial in 2017. The incorporation of TTFields, alongside cyclic temozolomide therapy, has demonstrated improved patient outcomes when the usage exceeds 18 h pe...

Descrizione completa

Salvato in:
Autori principali: Claudius Jelgersma, Joan Alsolivany, Gülsüm Akkas, David Wasilewski, Bastian Gastl, Martin Misch, David Capper, David Kaul, Lars Bullinger, Peter Vajkoczy, Julia Onken
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2025-01-01
Serie:Frontiers in Oncology
Soggetti:
tumor treating fields (TTFields)
malignant glioma
glioblastoma
compliance
usage
adherence
Accesso online:https://www.frontiersin.org/articles/10.3389/fonc.2024.1430793/full
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi